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1. Introduction  
Long-chain polyunsaturated fatty acids (LCPUFAs) play an important role in the human 
body in building up cell membranes and in regulating their fluidity. The most important 
fatty acids are the essential n-3 fatty acid, alpha-linolenic acid (C18:3n-3, ALA) and the 
essential n-6 fatty acid, linoleic acid (C18:2n-6, LA), and their most important metabolites, 
docosahexaenoic acid (C22:6n-3, DHA) and arachidonic acid (C20:4n-6, AA). LCPUFAs are 
precursors of different eicosanoids, and their availability may be disturbed in several 
diseases. As insulin is one of the most potent activators of -6 desaturase enzyme, type 1 
diabetes mellitus (T1DM) is characterised by the diminished levels of n-3 LCPUFAs (Decsi 
et al., 2002, 2007; Szabó et al., 2010b). 
2. Role of polyunsaturated fatty acids 
Polyunsaturated fatty acids (PUFAs) are components of the lipid bilayer of cell membranes, 
where they also regulate membrane fluidity. Cell membranes containing more saturated 
fatty acids and cholesterol are more rigid, while PUFAs increase their fluidity as well as the 
number of receptors and their affinity to their substrates, like hormones and growth factors 
(Das, 2006).  
PUFAs are also precursors of several second messengers. From the n-6 group, especially 
from AA proinflammatory eicosanoids are synthesized, while the n-3 fatty acids, especially 
eicosapentaenoic acid (C20:5n-3, EPA) are precursors of antiinflammatory eicosanoids. 
The n-6 essential fatty acid (EFA), LA plays an important role in the maintenance of the 
epidermal water barrier (Koletzko & Rodriguez-Palmero, 1999), preventing thereby the 
transepidermal water loss and epidermal damage (Yen et al., 2008). There are data 
indicating that LA also lowers plasma total cholesterol levels (Nikkari et al., 1983). In an 
animal study the n-3 EFA, ALA lowered serum and liver triacylglycerol levels, while it 
increased serum HDL-cholesterol levels (Murano et al., 2007). 
AA and DHA play an important role in the maturation of the developing nervous system: 
during the third trimester and in the first months of life there is an increased incorporation 
into the fetal/neonatal brain and retinal membranes (Farquharson et al., 1992; Martinez & 
Mougan, 1998). 
Fish oil, containing EPA and DHA, may be beneficial not only during infancy, but also 
during adulthood. It may prevent the development of macula degeneration (Chua et al., 
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2006), may lower the risk of developing dementia and Alzheimer-disease (Morris et al., 
2003; Schaefer et al., 2006) and may be beneficial in bipolar depression (Noaghiul & Hibbeln, 
2003). N-3 LCPUFAs play also an important role in the prevention of cardiovascular 
diseases: fish oil supplementation increased HDL-cholesterol levels, while decreased 
triacylglycerol levels (Laidlaw & Holub, 2003), reduced the progression of atherosclerosis 
(Erkkilä et al., 2004), the risk of coronary heart disease (Iso et al., 2006; Mozaffarian et al., 
2005), fatal myocardial infarction (Yuan et al., 2001), sudden cardial death (Albert et al., 
1998), incidence of atrial fibrillation (Mozaffarian et al., 2004) and the risk of stroke 
(Mozaffarian et al., 2005). In a longitudinal, observational study, fish oil supplementation 
reduced the risk of developing islet autoimmunity in children at increased genetic risk for 
T1DM (Norris et al, 2007). 
Trans isomeric fatty acids increase serum lipoprotein(a), LDL-cholesterol, triacylglycerol 
(Katan et al., 1995) and total cholesterol levels (Louheranta et al., 1999), as well as 
significantly decrease the levels of HDL-cholesterol (Dyerberg et al., 2004; Louheranta et al., 
1999; Sun et al., 2007); in summary, they increase the risk of cardiovascular diseases (Sun et 
al., 2007). In an animal study rats fed with trans fatty acid diet (similar to saturated fatty acid 
diet) had high levels of fasting plasma insulin and decreased adipocyte insulin sensitivity 
(Ibrahim et al., 2005). In contrast, in a human study trans fatty acid diet did not alter insulin 
sensitivity (Louheranta et al., 1999). 
2.1 Biochemistry of fatty acids 
The physiologically most important PUFAs contain 2-6 double bonds and have a chain 
length of 18, 20 or 22 carbon atom. The methyl end of the molecule is called the omega end. 
On the basis of the distance of the first double bond from the carbon atom at the omega end, 
three different groups of fatty acids can be distinguished: omega-3 (n-3), omega-6 (n-6) and 
omega-9 (n-9) fatty acids. 
The human body is unable to establish double bond in the n-3 and n-6 position, so we have 
to ingest the EFAs, the n-3 ALA and n-6 LA with our diet. The most important dietary 
sources of these fatty acids are vegetables and vegetable oils.  
From the essential n-6 LA, after -6 desaturation Ǆ-linolenic acid (C18:3n-6, GLA) and after 
elongation dihomo-Ǆ-linolenic acid (C20:3n-6, DHGLA) is synthesised. After a -6 
desaturational step, the most important metabolite, AA is produced (Fig. 1). 
The metabolism of the n-3 group is a longer, more complicated process. After elongation,  
-5 and -6 desaturation eicosapentaenoic acid (C20:5n-3, EPA) is formed. After chain 
elongation docosapentaenoic acid (C22:5n-3, DPA) is synthesised. The most important n-3 
metabolite, DHA is produced after -6 desaturation and peroxisomal ǃ-oxidation (Fig. 1). 
Although the same enzymes are involved into the metabolism of the n-3 and n-6 group, 
these fatty acids cannot be transformed into each other, because the molecule can only be 
activated from the carboxyl end. In the metabolism, the elongation is a quicker, while 
desaturation is a slower step, so these desaturational steps determine the speed of 
metabolism (i.e. these are the rate-limiting steps). 
In the nature, PUFAs can be found predominantly as cis isomers, while trans fatty acids are 
produced in the stomach of ruminants and during the partial hydrogenation of vegetable oils. 
Cis double bond bends the molecule, while trans double bond straightens the fatty acid, so it is 
similar to saturated fatty acids. From this difference arise their different physiological effects: 
trans isomers are similar to saturated fatty acids, while cis isomers have more beneficial effects. 
As cis and trans fatty acids use the same enzymes during their metabolism, several studies 
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have indicated, that trans fatty acids may disturb the metabolism of the physiologically 
important n-3 and n-6 fatty acids (Szabó et al, 2007, 2010a; Vidgren et al., 1998). 
 
 
Fig. 1. Metabolism of n-6 and n-3 fatty acids 
figure modified from http://www.lpi.oregonstate.edu; source of fatty acid figures: 
http://www.3dchem.com/index.asp 
2.2 Dietary sources of fatty acids 
The n-3 EFA, ALA is found in the highest quantity in linseed oil, and considerable amounts 
are found in hempseed oil (20%) as well (Erasmus, 1993); however, from the dietary point of 
view its most important sources are walnut and rapeseed oils (Beare-Rogers et al., 2001). The 
n-6 EFA, LA can be found in the highest proportion in primrose (81%; Erasmus, 1993) and 
grapeseed oils, but its most important dietary sources are sunflower, corn and pumpkin 
seed oils (Table 1; Beare-Rogers et al., 2001). Compared to vegetable sources, animal lipid 
sources contain smaller quantities of ALA and LA (Table 2). 
Flesh of herbivorous animals is very rich in the most important n-6 metabolite, AA (Table 2). 
On the other hand, haslets of terrestrial animals, like liver and kidney contains DHA also in 
relative high concentrations. 
The most important n-3 LCPUFAs, EPA and DHA can be found in fatty sea fishes (Table 3). 
The DHA content of sea fishes may vary according to season, area of catching and to age and 
gender of the fish (Racine & Deckelbaum, 2007). Marine fish contains higher levels of n-3 
PUFAs, EPA and DHA, while lower n-6 PUFAs, LA and AA compared to freshwater 
species. In a Chinese study, the edible meat of cultured freshwater fish contained more n-3 
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PUFAs, EPA and DHA, than the meat of wild freshwater fish (Li et al., 2011). Fatty acid 
composition of fishes living in the Mediterranean Sea showed seasonal variation (mackerel: 
lowest in winter-14.44%, highest in spring-38.27%; European eel: lowest in autumn-7.88%, 
highest in spring-9.46%; Soriguer et al., 1997). 
 
 LA ALA 
Corn oil* 39.4-65.6 0.5-1.5 
Grapeseed oil* 58-78 <1.0 
Linseed oil* 17-30 47-55 
Olive oil* 3.5-20.0 0.0-1.5 
Palm kernel oil* 6.5-12 <0.5 
Pumpkin seed oil# 42-57 0-15 
Rapeseed oil* 11-23 5-13 
Sesame oil* 41.5-47.9 0.3-0.4 
Soya bean oil 49.8-57.1 5.5-9.5 
Sunflower oil (high LA content)* 65.7 − 
Walnut oil* 52.9 10.4 
* data modified from Beare-Rogers et al., 2001 
# data modified from Erasmus, 1993 
Table 1. Fatty acid composition (g fatty acid/100 g fat) of selected vegetable sources, fats 
and oils 
 
 LA ALA AA DHA 
Chicken flesh 26.5 1.1 1.7 0.6 
Duck flesh 13.9 1.5 − − 
Heart (beef) 20.9 10.5 0.5 − 
Kidney (lamb) 9.7 3.4 6.4 1.5 
Kidney (veal) 13.4 1.7 7.8 0.7 
Lamb 6.2 0.7 0.7 − 
Liver (chicken) 14.0 4.2 0.3 2.0 
Liver (pork) 13.6 17.2 1.3 1.0 
Milk (cow) 2.6 1.6 − − 
Rabbit 20.2 5.2 − − 
Turkey flesh 24.2 1.3 2.3 0.5 
Veal 9.4 0.6 2.3 − 
Venison 14.6 3.3 4.7 − 
Table 2. Fatty acid composition (g fatty acid/100 g fat) of selected terrestrial animal lipid 
sources (data modified from Beare-Rogers et al., 2001) 
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 LA ALA AA DHA 
High fat fishes (>8%)*     
Blue fish, mature (31.3%)* 2.2 n.d. 4.2 13.8 
Horse mackerel (12.8%) * 1.1 n.d. 1.4 6.6 
Rainbow trout (9.0%)# 5.4 1.4 0.8 10.8 
Sardine (11.3%)* 2.2 1.4 2.6 14.7 
Striped mullet (11.0%)* 2.7 0.73 3.1 11.7 
Medium fat fishes (4-8%)*     
Anchovy (7.1%)* 2.8 1.4 2.4 16.2 
Atlantic mackerel (6.1%)* 2.1 0.68 2.8 25.3 
Crucian carp, wild (6.02%)$ 11.4 4.0 3.6 5.0 
Mackerel (7.45%)# 1.9 2.3 1.7 15.9 
Silver carp (5.36%)$ 2.4 4.4 4.9 15.5 
White herring (6.88%)$ 1.2 3.6 2.8 11.8 
Low fat fishes (2-4%)*     
Anchovy (3.49%)# 1.5 2.2 1.4 25.5 
Crucian carp, cultured (3.60%)$ 17.0 2.6 4.0 6.7 
Swordfish (1.93%)# 0.7 1.0 1.1 9.3 
Tuna (1.16%)# 2.3 1.3 1.8 16.9 
data modified from: * Tanakol et al., 1999 [Black & Marmara Sea]; # Soriguer et al., 1997 [Atlantic Ocean 
& Mediterranean Sea]; $Li et al., 2011 [East China Sea & Quiantang River] 
Table 3. Fat content and fatty acid composition (g fatty acid/100 g fat) of selected sea fishes  
2.3 Fatty acids during pregnancy 
LCPUFAs play an important role in the maturation of the developing nervous system. AA 
and DHA are accreted in large amounts into the fetal nervous system: into the cortex and 
retinal cell membranes during the third trimester of pregnancy and in the first months of life 
(Farquharson et al., 1992; Martinez & Mougan, 1998). DHA can be predominantly found in 
the grey matter and retina (Horrocks & Yeo, 1999), while the highest AA content is in the 
amygdala (Brenna & Diau, 2007). In a primate study (Diau et al., 2005), the highest DHA 
content was found in globus pallidus (15.8%), while the lowest in the optic nerve (4.5%). AA 
content was the highest in the amygdale (13.7%) and the lowest in the optic tract (6.8%). 
Grey matter was richer is both AA and DHA, but there was a discontinuity between grey 
and white matter DHA concentration, while this great difference wasn’t seen in AA 
concentrations. 
The human body has the enzymes needed to synthesise LCPUFAs from their parent essential 
fatty acids, but the synthesis is a very slow, limited process. In vivo human studies showed 
that from ALA only a little part is metabolised into EPA and DHA: when supplementing ALA 
in low dose (<100 mg) only 1.5-7.0% EPA and max. 0.3% DHA were synthesised, while 
supplementing ALA in high dose (>100 mg) resulted in the synthesis of 0.2-9.0% EPA and 3.8-
10.4% DHA. Hence, rise of EPA by 20-100% can be seen in a dose-dependent manner after the 
administration of ALA. In contrast, the change in DHA values is rather negligible in healthy 
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adults. Similarly, LA supplementation has little effect on AA supply, only ~0.1% of dietary LA 
is converted to AA in healthy adults (Plourde & Cunnane, 2007). 
As AA and DHA play a key role in the fetal and neonatal brain and visual development, 
several authors investigated whether the fetus and/or the infant is capable to synthesise AA 
and DHA from LA and ALA, respectively. In an experimental study (Salem et al., 1996), in 
vivo conversion of EFAs in newborns was investigated. After the administration of 
deuterium-labeled LA and ALA, deuterium-labeled AA, EPA and DHA appeared in the 
neonatal blood. However, this capacity can hardly cover the LCPUFA requirement of the 
developing brain. Two groups of infants with sudden and unexpected death were studied 
(at the age of 2 to 48 weeks) and significantly higher AA and DHA values were found in 
erythrocyte and brain cortex lipids in breastfed infants than in infants fed formula that 
contained only LA and ALA, and the accretion of DHA was correlated with the length of 
breastfeeding (Makrides et al., 1994).  
Since LCPUFA synthesis in the human organism is limited, the most important source of 
AA and DHA is diet. During pregnancy maternal diet covers the fetal requirements of these 
fatty acids, while after delivery either maternal diet (breastfeeding) or the independent diet 
of the infant (formula feeding). In an animal study (Diau et al., 2005), baboon neonates were 
fed either breastmilk or formula with or without AA and DHA. DHA supplementation 
restored the DHA supply in the grey matter to breastfed levels, while dietary AA had little 
effect on brain AA content. In other words: AA seems to be less sensitive to dietary 
manipulation than DHA. 
Maternal diet and metabolism as well as maternal stores are the sources of fetal fatty acid 
supply. As the ability of the fetus to synthesise LCPUFAs is limited, placenta plays an 
important role in transferring AA and DHA from mother to the fetus. Several research 
groups (Berghaus et al., 1998; Gil-Sanchez et al., 2010; Ortega-Senovilla et al., 2009) 
investigated the differences in maternal and fetal (newborn) blood fatty acid composition 
and found a higher proportion of LCPUFAs, while lower proportion of the EFAs in the fetal 
circulation than in the mothers. This phenomenon is called “biomagnification” and may be 
related to the ability of the placenta to selectively transport LCPUFAs to the fetus. In an in 
vivo study (Larqué et al., 2003), pregnant women undergoing elective caesarean section 
received 4 h before delivery an oral dose of 13C-labeled palmitic acid, oleic acid, LA and 
DHA. Venous blood was taken from the mothers every hour, and cord blood and placental 
tissues were also collected at delivery. All four fatty acids appeared in the placental tissues 
and cord blood triacylglycerol (TG) and non-esterified fatty acid (NEFA) lipids, and there 
was a preferential sequestration of DHA into the placenta. In a recent study (Gil-Sanchez et 
al., 2010), it was also shown that all labeled fatty acids were enriched in maternal plasma, as 
well as placental and cord blood lipids. This was the first study that showed a higher ratio 
of 13C-labeled DHA in cord to maternal plasma. Unesterified fatty acids are transferred to 
the fetal circulation by both passive diffusion and through a complex, saturable, protein-
mediated transport (Koletzko et al., 2007a). There are several fatty acid transfer proteins in 
the placenta, like fatty acid binding protein (FABP), that preferentially binds LCPUFAs, 
fatty acid translocase (FAT) and fatty acid transporter protein (FATP) located on both sides 
of trophoblast cells transporting fatty acids bidirectionally (Cetin et al., 2009). The plasma 
membrane FABP is located exclusively on the maternal side of membranes and might be 
involved in the preferential uptake of LCPUFAs by these cells (Koletzko et al., 2007a).  
Fish or fish oil intake during pregnancy and lactation improves maternal fatty acid supply 
and, hence, may enhance fetal DHA concentrations. The increased DHA intake during 
pregnancy resulted in better visual and neural development in infants at the age of 18 
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months (Bouwstra et al., 2006), 3.5 years (Williams et al., 2001) and 4 years (Helland et al., 
2003), while other studies failed to corroborate these findings (Bakker et al., 2003; Ghys et 
al., 2002). Because of the beneficial fetal/neonatal effects of n-3 LCPUFAs, for pregnant and 
lactating women, at least 200 mg/day DHA intake is recommended (Koletzko et al., 2007b). 
3. Effect of type 1 diabetes mellitus on fatty acid supply 
T1DM disturbs not only the carbohydrate, but also the lipid metabolism. The most 
extensively studied experimental animal model of T1DM is the alloxane or streptozotocin-
induced diabetic rat or mouse. The results of animal studies are quite unequivocal: in 
diabetic animals significantly higher LA contents were found in liver, renal cortex and heart 
lipids (Ramsammy et al., 1993), in liver microsomes and erythrocyte membranes (Shin et al., 
1995) as well as in plasma, liver and skeletal muscle phospholipids (Mohan & Das, 2001), 
while its most important metabolite, AA was significantly decreased in diabetic animals. 
These results can be explained with the diminished activity of -5 (Ramsammy et al., 1993) 
and -6 desaturase enzymes in T1DM (Ramsammy et al., 1993; Shin et al., 1995). On the 
basis of these animal studies, insulin is considered as the most potent activator of both -5 
and -6 desaturase enzymes (Brenner, 2003). 
Human studies are even less unambiguous than animal observations. Some studies found 
significantly higher LA values in diabetic patients (Decsi et al., 2002, 2007; Tilvis & 
Miettinen, 1985), while others found no significant differences (Ruiz-Gutierrez et al., 1993; 
Seigneur et al., 1994). On the other hand, most studies report significantly lower AA (Decsi 
et al., 2002; Ruiz-Gutierrez et al., 1993) and DHA values (Decsi et al., 2002; Ruiz-Gutierrez et 
al., 1993; Tilvis & Miettinen, 1985) in diabetic patients than in controls. In one study (Tilvis et 
al., 1986), diabetic patients treated with continuous insulin infusion therapy had 
significantly lower LA, and significantly higher AA and DHA values both in plasma and 
erythrocyte membrane lipids than patients with conventional insulin therapy. These results 
suggest that better diabetic control may improve the activity of -6 desaturase enzyme. 
After a longer period, hyperglycaemia and hypoinsulinemia may lead to several 
complications in diabetic patients. Several studies investigated the relationship between 
disturbed fatty acid status in diabetic patients and a number of complications, like diabetic 
neuropathy, nephropathy and retinopathy. These relationships and the potential role of n-3 
fatty acid supplementation in diabetic patients are reviewed elsewhere (Szabó et al., 2010b). 
3.1 Fatty acid supply during pregnancy in women with type 1 diabetes mellitus: 
Maternal effects 
T1DM disturbs the fatty acid supply, therefore maternal LCPUFA stores may be 
compromised compared to healthy pregnant women. Disturbed fatty acid supply and 
metabolism may influence the course of pregnancy and delivery and may lead both to 
maternal and fetal complications. Nevertheless, we found only two human studies 
investigating the fatty acid supply during pregnancy in women with T1DM and four studies 
investigating fatty acid supply in cord blood lipids of newborns born from mothers with 
T1DM (Table 4). 
Ghebremeskel et al. (Ghebremeskel et al., 2002) induced diabetes with streptozotocin in 
pregnant rats and investigated the liver fatty acid composition. They found significantly 
higher essential fatty acid values (ALA and LA) as well as n-3 and n-6 LCPUFA values (AA, 
EPA, DPA and DHA) in the TG and NEFA fractions. In an earlier study (Chen CH et al., 
www.intechopen.com
 
Type 1 Diabetes – Complications, Pathogenesis, and Alternative Treatments 
 
444 
1965), only LA was determined and no significant differences were found in plasma NEFA 
fraction between diabetic and control mothers.  
 
Author Number Change in EFAs Change in LCPUFAs 
T1DM: maternal 
effects 
   
Chen CH et al., 1965 n = 3 pl. NEFA: LA ņ no data 
Min et al., 2005a n = 32 
pl. TG, CPG: LA, ALA ņ 
RBC PC, PE: LA, ALA ņ 
pl. CPG: DHA Ņ 
RBC PC: DPA, DHA Ņ 
RBC PE: DHA Ņ 
T1DM: fetal effects    
Chen CH et al., 1965 n = 4 pl. NEFA: LA ņ no data 
Ghebremeskel et al., 
2004 
n = 31 
pl. CPG: LA, ALA ↑ 
pl. TG: LA, ALA Ņ 
pl. STE: LA, ALA ņ 
pl. CPG: AA, DPA, DHA Ņ 
pl. TG: DHGLA Ņ 
pl. STE: AA, DHA Ņ 
Min et al., 2005a n = 26 
pl. TG: ALA Ņ 
pl. CPG: LA, ALA ņ 
RBC PC, PE: LA, ALA ņ 
pl. TG: DHGLA, DPA, 
DHA Ņ 
pl. CPG: AA, DHA Ņ 
RBC PC: AA, DHA ņ 
RBC PE: DHA Ņ 
Winkler et al., 2008* 
a.) n = 23
 
b.) n = 25
a.) RBC PC, PE: LA, ALA ņ
b.) RBC PE: LA, ALA ↑ 
RBC PC: LA, ALA ņ 
a.) RBC PC: DPA Ņ 
RBC PE: AA, DHA ņ 
b.) RBC PE: DHA Ņ 
RBC PC: AA, DHA ņ 
* a.) = age of 3 months; b.) = age of 12 months 
Abbreviations: AA: arachidonic acid, ALA: alpha-linolenic acid, CPG: choline phosphoglycerol, DHA: 
docosahexaenoic acid, DHGLA: dihomo-gamma-linolenic acid, DPA: docosapentaenoic acid, EFAs: 
essential fatty acids, EPA: eicosapentaenoic acid, LA: linoleic acid, LCPUFAs: long-chain 
polyunsaturated fatty acids, NEFA: non-esterified fatty acid, PC: phosphatidylcholine, PE: 
phosphatidylethanolamine, pl.: plasma, PL: phospholipid, RBC: erythrocyte, SM: sphyngomyeline, STE: 
sterol esther, T1DM: type 1 diabetes mellitus, TG: triacylglycerol 
Table 4. Change in essential fatty acid and long-chain polyunsaturated fatty acid values 
compared to controls in pregnant women with type 1 diabetes mellitus and newborns from 
mothers with type 1 diabetes mellitus 
Plasma and erythrocyte membrane fatty acid composition was studied in women with and 
without T1DM at midgestation (Min et al., 2005a). In the maternal plasma only choline 
phosphoglyceride (CPG) DHA was found to be decreased in diabetic patients, while in the 
erythrocyte membrane lipids more pronounced differences were found. Both the 
phosphatidylcholine (PC) fraction and in the phosphatidylethanolamine (PE) fraction 
significantly lower DHA values were found in mothers with T1DM than in healthy pregnant 
women. The authors hypothesised that this difference might be due to the synergistic effect 
of diabetes and pregnancy. 
3.2 Fatty acid supply in newborns of mothers with type 1 diabetes mellitus: Fetal 
effects 
AA and DHA play an important role in the maturation of the fetal nervous system. 
Although the developing fetus can synthesise AA and DHA from their precursors, this 
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synthesis is rather slow and can’t meet the requirements of the fetus. As T1DM disturbs the 
fatty acid supply of pregnant women, newborns of mothers with diabetes may have 
inadequate in utero n-3 and n-6 LCPUFA supply. In contrast to the lack of data on maternal 
fatty acid supply, cord blood lipids in neonates of mothers with T1DM were published from 
several studies. 
Chen CH et al. (Chen CH et al., 1965) found no differences between cord blood LA values 
between newborns of diabetic and control mothers. Cord blood of newborns from mothers 
with T1DM and healthy controls was analysed in detail in an English study (Ghebremeskel 
et al., 2004). In the plasma CPG fraction there were significantly higher LA and ALA values 
in cord blood of neonates from diabetic mothers, while their long-chain metabolites, AA and 
DHA were lower in both plasma CPG and sterin esther (STE) fractions, which may reflect 
impaired placental transfer of the n-3 and n-6 LCPUFAs. The authors speculated that the 
effect of T1DM and pregnancy-induced metabolic changes together with the Western diet 
might have resulted in decreased AA and DHA levels in pregnant women with T1DM. 
In another study, cord blood samples of newborns of mothers with T1DM contained 
significantly lower ALA, DPA and DHA in the plasma TG fraction and significantly lower 
AA and DHA in the plasma CPG fraction (Min et al., 2005a). However, only DHA values 
were decreased in the erythrocyte PE fraction in the cord blood of the T1DM group. 
In the BABYDIET study, newborns with increased genetic and familiar risk for T1DM  were 
investigated (Winkler et al., 2008). Erythrocyte membrane PC and PE were determined in 
infants of mothers with and without T1DM at the age of 3 and 12 months. No differences 
were found in the values of the most important LCPUFAs, AA and DHA in the PC fraction, 
while significantly lower DPA values were found in the infants of diabetic mothers at the 
age of 3 months, than in those of the healthy controls. In contrast, comparing only the 
exclusively breastfed infants of mothers with and without T1DM, no differences were found 
in the values of n-3 and n-6 PUFAs. At the age of 12 months, infants from mothers with 
T1DM had significantly higher essential fatty acid (ALA and LA) values, but DHA values 
were decreased in the PE fraction. 
As newborns of mothers with diabetes may have diminished AA and DHA supply, the 
neurodevelopment of these infants may also be affected. In an experimental animal study 
(Zhao et al., 2009), diabetes was induced in rats who were divided into two groups, one with 
good and one with poor diabetic control and were fed either with AA or control diet. After 
one week the animals were mated and the neurodevelopment of the pups was investigated. 
Maternal dietary AA supplementation through pregnancy and lactation resulted in 
improved sensorimotor and developmental performances of the offspring of both healthy 
controls and poorly controlled diabetic dams. Maternal AA supplementation also improved 
the AA supply of the offspring’s liver, but not in the brain. 
Maternal diabetes may disturb fetal fatty acid supply, however, from the epidemiological 
point of view the longer term effects are more important. Offspring of diabetic mothers may 
develop different malformations such as spina bifida, at birth they might be macrosomic 
and develop hypoglycaemia. The potential role of fatty acids in hyperglycaemia-induced 
teratogenesis was studied in an experimental animal model (Goldman et al., 1985). Diabetic 
pregnant rats without insulin treatment received subcutaneous AA injection during the 
period of organogenesis and although maternal glucose concentration didn’t change, there 
was a significant decrease in the incidence of neural tube defects (from 11% to 3.8%), 
micrognathia (from 7% to 0.8%) and cleft palate (from 11% to 4%). These data suggest that 
beside good diabetes control also AA supplementation in diabetes might reduce the 
teratogenetic effect of hyperglycaemia. 
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4. Effect of gestational diabetes mellitus on fatty acid supply 
Gestational diabetes mellitus (GDM) affecting 2-10% of pregnant women in the United 
States (National Diabetes Statistics, 2011) is associated with insulin resistance during 
pregnancy. Its prevalence is rising worldwide. Analysing the GDM screening results 
between 1994-2002 in Colorado state (Dabelea et al., 2005), the prevalence of GDM was 
increasing from 1994-1996 to 2000-2002 in all ethnic groups: Hispanic (2.8% to 5.1%), African 
American (2.5% to 4.6%), Asian (6.3% to 8.6%) and non-Hispanic white (1.9% to 3.4%). 
Women with GDM are at risk to develop type 2 diabetes mellitus either immediately after 
delivery (5-10%) or later, in 10-20 years (35-60%).  
The risk factors of developing GDM during pregnancy are higher pre-pregnancy BMI, 
smoking, increasing maternal age and GDM during previous pregnancy. Western diet 
contains high fat intake with high n-6/n-3 fatty acid ratio, refined sugar, fried and snack 
foods with high trans fatty acid content; all these factors may play an important role in 
developing impaired glucose tolerance and, hence, GDM. Maternal high fat diet during 
pregnancy decreased EPA and DHA values in liver in newborn pups as well as in suckling 
pups born from both diabetic and control mothers (Ghebremeskel et al., 1999). In the Project 
Viva (Radesky et al., 2008), pregnant women with maternal age above 40 years (OR: 11.3), 
pre-pregnancy BMI above 30 kg/m2 (OR: 3.44), GDM during prior pregnancy (OR: 58.3) and 
Hispanic ethnicity (OR: 3.19) had increased risk of developing GDM. However, dietary 
pattern during early pregnancy had no association with developing GDM. 
4.1 Fatty acid supply during pregnancy in women with gestational diabetes mellitus: 
Maternal effects 
As type 2 diabetes mellitus and obesity disturbs fatty acid supply, GDM may also have an 
effect on fatty acid metabolism in pregnant women. While only two studies were found 
investigating the effect of T1DM on maternal blood fatty acid composition, GDM was 
investigated in a number of studies. We found nine studies investigating the fatty acid 
supply during pregnancy in women with GDM and five studies investigating the fatty acid 
supply of newborns from mothers with GDM (Table 5). 
In an early study (Chen CH et al., 1965), no difference was seen in LA values of mothers 
with GDM and controls at delivery. When in 2000 the diet and blood samples of pregnant 
women with GDM during the third trimester were analysed (Wijendran et al., 2000) women 
with GDM had significantly higher AA, EPA and DHA intakes than controls. Maternal 
erythrocyte PL contained more DHA, while other fatty acids didn’t differ. The authors also 
determined the effect of fatty acid supply on plasma PL in these women at the 27-30th, 33-
35th and 36-39th weeks of pregnancy (Wijendran et al., 1999). Although there were no 
significant differences in the LA and AA values between the two groups, values of DHGLA 
and C22:5n-6 were significantly lower at each investigated time points. In contrast, among 
the n-3 fatty acids, ALA and DPA were significantly lower, while DHA was significantly 
higher in women with GDM than in healthy controls. Wijendran et al. provided three 
possible explanations for the lower ALA and higher DHA values: 1. either increased 
desaturation and elongation of ALA to DHA may be responsible for these alterations, or 2. 
increased selective oxidation of ALA or 3. enhanced release of DHA into plasma PL. Both in 
controls and mothers with GDM, the n-3 and n-6 LCPUFAs decreased as the result of the 
physiologic adaptation in pregnant women to the increased fetal n-3 and n-6 LCPUFA 
requirement during the third trimester. The authors also investigated the correlations 
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Author Number Change in EFAs Change in LCPUFAs 
GDM: maternal effects 
Chen CH et al., 1965 n = 8 pl. NEFA: LA ņ no data
Chen X et al., 2010 n = 49 pl.: LA, ALA ↑ pl.: AA, EPA, DHA ↑ 
Min et al., 2004 n = 53 
pl. CPG: ALA Ņ 
RBC PC: ALA Ņ 
RBC PE: ALA ↑ 
pl. CPG: AA ↑ 
RBC PC: DHGLA, AA, 
EPA, DPA, DHA Ņ 
RBC PE: DHGLA, DPA, 
DHA Ņ 
Min et al., 2005b n = 40 
pl. TG: LA, ALA ņ 
pl. CPG: ALA Ņ 
RBC PC, PE: LA, ALA ņ 
pl. TG: AA, DHA ņ 
pl. CPG: AA ↑ 
RBC PC: AA Ņ 
RBC PE: AA, DHA ņ 
Min et al., 2006 n = 12 
pl. TG: LA, ALA ņ 
pl. PC: ALA Ņ 
pl. SM: LA ņ 
RBC PC, PE: LA, ALA ņ 
RBC SM: LA ņ 
pl. TG: AA, DHA ņ 
pl. PC: DHA ↑ 
pl. SM: AA, DHA ņ 
RBC PC: AA Ņ 
RBC PE: AA Ņ 
RBC SM: AA, DHA ņ 
Ortega-Senovilla et al., 
2009 
n = 15 pl.: LA, ALA ņ pl.: AA, DHA ņ 
Thomas et al., 2004 n = 44 
pl. CPG: ALA Ņ
pl. TG: LA ↑ 
pl. STE: ALA Ņ 
pl. CPG: AA ↑ 
pl. TG: DHA ↑ 
pl. STE: AA ↑ 
Wijendran et al., 1999 n = 15 pl. PL: ALA Ņ pl. PL: DHGLA, DPA Ņ, 
DHA ↑ 
Wijendran et al., 2000 n = 13 RBC PL: ALA Ņ RBC PL: DHA ↑ 
GDM: fetal effects 
Chen CH et al., 1965 n = 9 pl. NEFA: LA ņ no data
Min et al., 2005b n = 40 
pl. TG: LA, ALA Ņ 
pl. CPG: LA, ALA ņ 
RBC PC, PE: LA, ALA ņ 
pl. TG: AA, DHA ņ 
pl. CPG: DHA Ņ 
RBC PC: DHA Ņ 
RBC PE: AA, DHA ņ 
Ortega-Senovilla et al., 
2009* 
n = 15 
a.) pl.: LA, ALA ņ
b.) pl.: LA, ALA ņ 
a.) pl.: AA, DHA ņ 
b.) pl.: AA, DHA Ņ 
Thomas et al., 2005 n = 37 
pl. TG: ALA Ņ 
pl. CPG, STE: LA, ALA ņ 
pl. CPG: DHGLA, DHA Ņ 
pl. STE: DHGLA Ņ 
pl. TG: AA, DHA ņ 
Wijendran et al., 2000 n = 13 RBC PL: LA, ALA ņ RBC PL: AA, DHA Ņ 
* a.) = umbilical vein; b.) = umbilical artery. Abbreviations: see Table 4. 
Table 5. Change in essential fatty acid and long-chain polyunsaturated fatty acid values 
compared to controls in mothers with gestational diabetes mellitus and infants born from 
mothers with gestational diabetes mellitus (GDM) 
between, on the one hand, maternal fatty acids and on the other hand, HbA1c and 
prepregnancy BMI. Though there was an inverse association between plasma HbA1c and 
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plasma PL AA also in the controls, this association was more pronounced in women with 
GDM. Similarly, positive correlation was found between mean fasting plasma insulin and 
plasma PL AA values. These correlations may indicate impairment in the transport of AA to 
the fetus. Prepregnancy BMI was correlated inversely to maternal DHA and positively to 
maternal AA values in the diabetic group. These findings suggest that maternal alterations 
in plasma PL DHA values may be more pronounced in obese women with GDM. 
An English research group (Thomas et al., 2006) investigated the diet of pregnant women 
with and without GDM during the third trimester, and reported several differences. 
Diabetic women ingested less fat than controls, and the ratios of fatty acids in the diet were 
also different: diabetic women had lower saturated, monounsaturated and trans fatty acid 
intake, but higher PUFA intake. Interestingly, the distribution of PUFAs was largely similar 
in the two groups, only one fatty acid differed between the two groups: mothers with GDM 
ingested more DHA. They also investigated the effect of ethnicity on dietary fatty acid 
intake. Afro-Caribbean mothers with GDM had lower total fat, saturated, monounsaturated, 
trans fatty acid and PUFA intake than Caucasian mothers. The diet of the Afro-Caribbean 
GDM group contained lower LA, AA, n-6 PUFA and ALA values, while higher EPA and 
DHA compared to Caucasian mothers with GDM. 
The same authors also compared the plasma fatty acid supply of these women at 
diagnosis (Thomas et al., 2004). Women with GDM had significantly higher LA values in 
the plasma TG fraction, higher AA values in the plasma CPG and STE fraction and higher 
DHA values in the plasma TG fraction than healthy controls, while ALA was significantly 
lower in plasma STE in women with GDM. These alterations may be explained by the 
high glucose concentration that led to the mobilisation of LA, ALA, AA and DHA from 
adipose tissue and liver. When comparing the fatty acid supply of both plasma and 
erythrocyte membrane lipids in these women at diagnosis (Min et al., 2004), in plasma 
CPG higher AA and lower ALA values were found in the mothers with GDM, while 
values of DHGLA, AA, C22:4n-6 as well as ALA, EPA, DPA and DHA was significantly 
lower in erythrocyte CPG lipids in the diabetic than in the control group. This discrepancy 
between plasma and erythrocyte membrane lipid composition may arise as an effect of 
GDM causing reduction of incorporation of these fatty acids into red blood cells and other 
tissues. As erythrocyte membrane lipid composition is very similar to that of the vascular 
endothelium, these alterations in erythrocyte membrane lipids may indicate that 
endothelium may be also affected in GDM. 
In another study carried out in London, significantly lower ALA and higher AA in plasma 
CPG fraction was found in diabetic mothers than in healthy controls at delivery (Min et al., 
2005b). However, AA was significantly lower in erythrocyte membrane PC fraction. 
Min et al. carried out a pilot study in Korea, where the habitual diet contains higher n-3 fatty 
acid and lower total fat intake than the typical Western-type diet (Min et al., 2006). Women 
with GDM had lower ALA and higher DHA in plasma PC fractions at delivery, while values 
of AA was lower in erythrocyte PC and PE fractions in women with GDM than in controls. 
Comparing the AA and DHA values in GDM patients and controls living in Korea or in the 
UK, in both study groups lower AA and DHA values were found in erythrocyte PC lipids of 
the GDM groups than in the controls. However, Korean women (both diabetic and control) 
had higher DHA values than British women. This finding suggests that the reduction of 
erythrocyte membrane AA and DHA values in women with GDM might be attributed to 
effects of the disease itself regardless of ethnicity, obesity or diet. In contrast, there were no 
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significant differences in the fatty acid composition of plasma lipids between mothers with 
GDM and controls at delivery in an Italian study (Ortega-Senovilla et al., 2009). 
As part of a prospective cohort study, a nested case-control study was carried out by Chen X 
et al. (Chen X et al., 2010) to investigate the differences in fatty acid status of women with 
impaired glucose tolerance, GDM and controls. In contrast to earlier studies (Wijendran et 
al., 2000; Thomas et al., 2006), this population had higher saturated fatty acid intake, while 
dietary LA, DHA and PUFA intakes were significantly lower in the diabetic group than in 
controls. At study entry (16th week) women who developed impaired glucose tolerance 
later, had higher plasma EPA absolute values; however, the percentage of PUFAs didn’t 
differ significantly among the three groups. During the third trimester, mothers with 
GDM had higher AA, DHA and PUFA absolute concentrations, while women with 
impaired glucose tolerance had higher LA, ALA, EPA and DHA absolute values. Similarly 
to study entry, PUFA percents didn’t differ among the groups. These data showed that 
not only GDM disturbs fatty acid supply of pregnant women, but impaired glucose 
tolerance as well. The authors also investigated the effect of BMI and found significantly 
higher concentrations of saturated and monounsaturated fatty acids and PUFAs in 
women with impaired glucose tolerance and BMI higher than 25 kg/m2 at study entry 
than in normal weighted women with impaired glucose tolerance. During the third 
trimester, overweight and obese women with GDM had the highest fatty acid absolute 
concentration. These results indicate that the disturbance in the fatty acid metabolism is 
more pronounced when beyond the mild hyperglycaemia obesity is also present. Results 
of this study raised the possibility that reducing pregravid weight and modifying diet 
(increasing PUFAs and reducing saturated fatty acids) may reduce circulating free fatty 
acids, therefore decreasing insulin resistance and inflammation and lower future maternal 
risk of type 2 diabetes mellitus. 
4.2 Fatty acid supply in newborns of mothers with gestational diabetes mellitus: Fetal 
effects 
Macrosomia and lipid abnormalities are common complications associated with maternal 
diabetes during pregnancy. Offspring of diabetic mothers are prone to develop obesity, type 
2 diabetes mellitus and cardiovascular diseases during adulthood. In an animal study 
(Soulimane-Mokhtari et al., 2008), diabetic and control rats were fed a control diet or diet 
rich in EPA and DHA. During pregnancy of the diabetic rats, VLDL- and LDL-cholesterol 
were significantly decreased in the intervention group. Moreover, similar changes were seen 
in the macrosomic offspring: maternal fish oil diet significantly decreased VLDL- and LDL-
cholesterol. As n-3 LCPUFA supplementation during pregnancy restored tissue lipase 
activities to normal range and ameliorated long-term prognosis of macrosomia, n-3 fatty 
acid supplementation may be beneficial for mothers with GDM. 
Maternal diabetes during pregnancy (characterised by hyperglycaemia, hyperlipidaemia, 
hyperlipoproteinaemia and altered T-cell function) may result in metabolic programming of 
the offspring causing obesity, impaired glucose tolerance, hyperlipidaemia and 
hyperlipoproteinaemia during adulthood (Khan, 2007). In Chinese children of mothers with 
GDM, significantly higher systolic and diastolic blood pressures and lower HDL-cholesterol 
levels were seen than in controls at the age of 8 years. High umbilical cord insulin was an 
independent risk factor of both abnormal glucose tolerance and obesity; hence, in utero 
hyperinsulinaemia and hyperglycaemia may have long-term effects on developing type 2 
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diabetes and metabolic syndrome (Tam et al., 2008). Type 2 diabetes was diagnosed at 
younger ages if the patients were exposed to maternal diabetes intrauterine, whereas this 
difference wasn’t seen in the onset of type 1 diabetes (Pettitt et al., 2008). This finding 
suggests, that intrauterine hyperglycaemia predisposes to an earlier onset of type 2 diabetes, 
while type 1 diabetes is little influenced by the intrauterine milieu. 
In the pioneer study published in 1965 by Chen CH et al. (Chen CH et al., 1965) newborns of 
mothers with GDM were also analysed and no differences were found in LA values between 
the diabetic and control groups. Wijendran et al. analysed not only the maternal diet and 
fatty acid composition of maternal erythrocyte PL, but also the fatty acid composition of 
cord blood erythrocyte membrane lipids (Wijendran et al., 2000). Though in the maternal 
blood only DHA differed between mothers with GDM and controls, in the cord blood 
several differences were found. Values of AA and n-6 PUFAs as well as DHA and n-3 
PUFAs were significantly lower in the GDM group than in controls. The DHA sufficiency 
index calculated from DHA divided with C22:5n-6 was also decreased. This impaired AA 
and DHA supply in cord blood suggested the impaired fetal accretion of these LCPUFAs in 
pregnancy with GDM. The authors also correlated maternal and fetal fatty acids both in the 
GDM group and controls. Though in controls significant positive correlations were found 
between maternal plasma PL AA and DHA and cord blood plasma PL AA and DHA, these 
correlations were lost in the GDM group. In controls also an enrichment of AA and DHA in 
fetal erythrocyte was found, while in the GDM group fetal DHA was lower than maternal, 
and no difference in AA values were found. These alterations raised the possibility that 
placental transfer of maternal LCPUFAs during the third trimester may be altered in GDM. 
Maternal HbA1c was also significantly and inversely correlated to fetal AA and DHA values. 
Although mothers had their HbA1c values between 4-6%, these values were significantly 
higher than in controls suggesting a moderate impairment of glucose control. This altered 
glucose control may also have a negative impact on fetal LCPUFA accretion. 
Min et al. (Min et al., 2005b) investigated cord blood samples of newborns from mothers 
with and without GDM in London and found significantly decreased ALA, LA, DHA and 
AA values in the plasma TG fraction. In contrast, in the plasma CPG fraction only DHA 
values were significantly lower in the diabetic group. Similarly, in the PC fraction of 
erythrocyte membrane lipids significantly decreased DHA values were found. This altered 
cord blood fatty acid supply may suggest the compromised placental fatty acid transport 
and/or fetal lipid metabolism. 
In another English study (Thomas et al., 2005) also significantly lower DHA values were 
found in the cord blood plasma CPG lipids in the diabetic group. DHGLA was also 
decreased in plasma CPG and STE fractions. Values of LA, ALA and AA were not 
significantly different between the two groups in the plasma TG, CPG and STE fractions, but 
values of AA were reduced. Although mothers with GDM consumed more DHA, their 
neonates had reduced levels of both DHA and AA, suggesting that mothers with GDM have 
impaired placental transfer of LCPUFAs. Mead acid, which is considered as an indicator of 
shortage of EFAs, was increased in the plasma CPG and TG fractions. The elevated Mead 
acid values in the cord plasma TG and CPG fraction suggested fetal EFA deficiency. 
In a recent study (Ortega-Senovilla et al., 2009) umbilical arterial and venous plasma fatty acid 
composition was analysed in women with GDM and controls who underwent elective 
caesarean section. While there were no significant differences in umbilical venous blood fatty 
acids between the two groups, in the umbilical arterial blood significantly lower AA, n-6 
PUFA, DHA and n-3 PUFA values were found. Umbilical arterial and venous blood of both 
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GDM and control groups had lower LA and higher AA and DHA than their mothers. As 
umbilical venous blood comes from placental capillaries, these higher proportions of AA 
and DHA in umbilical venous than in maternal blood may indicate that the placental 
transfer remained unimpaired. However, the decreased n-3 and n-6 LCPUFA values might 
indicate enhanced utilization of these fatty acids. 
4.3 Differences between fatty acid supply in pregnant women with type 1 diabetes 
mellitus and with gestational diabetes 
We found ten studies about fatty acid supply of pregnant women with either T1DM or 
GDM. Five different research groups performed human investigations: Chen CH et al. from 
Cleveland, Chen X et al. from New Jersey, Min et al. from London (Min, Thomas), Ortega-
Senovilla et al. from Madrid, finally Wijendran et al. from Hartford. 
To the best of our knowledge, only one study investigated the LCPUFA supply in pregnant 
women with T1DM. In this study no differences were found in n-3 and n-6 EFA values, 
while the most important n-3 metabolite, DHA was lower in all lipid fractions. In GDM 
most of the studies found decreased or unchanged ALA values, while LA values remained 
in most cases stable. In case of LCPUFAs, the results are less unambiguous and there was a 
difference between plasma and erythrocyte LCPUFA values. In general we can say, that 
plasma LCPUFAs in most cases were higher in mothers with GDM than in controls or it 
remained unchanged. In contrast, in erythrocyte membrane lipids LCPUFAs were either 
lower or unchanged in women with GDM compared to healthy controls except for one 
study (Wijendran et al., 2000). 
Although we found only one study about fatty acid supply of pregnant women with T1DM, 
it seems, that diabetes had no influence on the EFA supply in mothers. In contrast, GDM 
may diminish EFA supply during pregnancy. T1DM significantly lowered the LCPUFA 
values in both plasma and erythrocyte membrane lipids, while there was a discrepancy in 
the effect of GDM: in plasma lipids it rather increased while in erythrocyte membrane lipids 
decreased the availability of LCPUFAs. 
4.4 Differences between fatty acid supply in neonates from mothers with type 1 
diabetes mellitus and with gestational diabetes 
There were seven human studies investigating the fatty acid supply in cord blood or blood 
from infants born from mother with either T1DM or GDM. Four different research groups 
have data about blood lipid fatty acid composition of these offspring: Min et al. from 
London (Ghebremeskel, Min, Thomas), Ortega-Senovilla et al. from Madrid, Wijendran et al. 
from Hartford, finally Winkler et al., from Munich. 
In contrast to maternal data, four studies investigated the fatty acid composition of 
newborns or infants of mothers with T1DM. Findings of EFA values are rather unequivocal: 
values of LA and ALA are either higher or lower or remained unchanged in the T1DM 
group. However, result are more clear in the case of LCPUFAs, all three studies found 
significantly lower AA and/or DHA values in plasma lipids, while erythrocyte membrane 
DHA values were either lower or similar to AA values, they remained unchanged in the 
offspring of T1DM mothers. 
Looking at the results about the effect of GDM, in most cases EFA values remained stable, 
while LCPUFAs, predominantly DHA was significantly lower in the GDM group. In cord 
blood there was no deviation between plasma and erythrocyte LCPUFA values: AA and 
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DHA were either lower or no significantly different in the offspring of GDM mothers than 
in controls. 
To sum it up: T1DM has no clear effect on EFA status of the offspring, while GDM might 
lower it. In contrast, both T1DM and GDM lowered the availability of LCPUFAs in 
newborns and infants of diabetic mothers. 
5. Conclusion 
Data reviewed here indicate that both T1DM and GDM disturb the fatty acid supply in 
pregnant women and their offspring. Both types of diabetes during pregnancy may result in 
lower values of n-3 and n-6 LCPUFA in maternal erythrocyte lipids as well as in cord blood 
plasma and erythrocyte lipids. Therefore incorporation of fatty sea fishes rich in n-3 fatty 
acids into the diet (e.g. in the form of two 200 g pieces weekly) or other ways of n-3 LCPUFA 
supplementation during pregnancy may be beneficial. 
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